CD4-independent infection by HIV-2 is mediated by Fusin/CXCR4

被引:598
作者
Endres, MJ
Clapham, PR
Marsh, M
Ahuja, M
Turner, JD
McKnight, A
Thomas, JF
StoebenauHaggarty, B
Choe, S
Vance, PJ
Wells, TNC
Power, CA
Sutterwala, SS
Doms, RW
Landau, NR
Hoxie, JA
机构
[1] INST CANC RES, CHESTER BEATTY LABS, LONDON SW3 6JB, ENGLAND
[2] UCL, DEPT BIOCHEM, MRC, MOL CELL BIOL LAB, LONDON WC1E 6BT, ENGLAND
[3] GLAXO WELLCOME RES & DEV SA, GENEVA BIOMED RES INST, CH-1228 PLAN LES OUATES, GENEVA, SWITZERLAND
[4] UNIV PENN, DEPT PATHOL & LAB MED, PHILADELPHIA, PA 19104 USA
[5] ROCKEFELLER UNIV, AARON DIAMOND AIDS RES CTR, NEW YORK, NY 10016 USA
基金
英国医学研究理事会;
关键词
D O I
10.1016/S0092-8674(00)81393-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Several members of the chemokine receptor family have been shown to function in association with CD4 to permit HIV-1 entry and infection. However, the mechanism by which these molecules serve as CD4-associated cofactors is unclear. In the present report, we show that one member of this family, termed Fusin/ CXCRL1, is able to function as an alternative receptor for some isolates of HIV-2 in the absence of CD4. This conclusion is supported by the finding that (1) CD4-independent infection by these viruses is inhibited by an anti-fusin monoclonal antibody, (2) Fusin expression renders human and nonhuman CD4-negative cell lines sensitive to HIV-P-induced syncytium induction and/or infection, and (3) Fusin is selectively downregulated from the cell surface following HIV-2 infection. The finding that one chemokine receptor can function as a primary viral receptor strongly suggests that the HIV envelope glycoprotein contains a binding site for these proteins and that differences in the affinity and/or the availability of this site can extend the host range of these viruses to include a number of CD4-negative cell types.
引用
收藏
页码:745 / 756
页数:12
相关论文
共 49 条
[1]   CC CKRS: A RANTES, MIP-1 alpha, MIP-1 beta receptor as a fusion cofactor for macrophage-tropic HIV-1 [J].
Alkhatib, G ;
Combadiere, C ;
Broder, CC ;
Feng, Y ;
Kennedy, PE ;
Murphy, PM ;
Berger, EA .
SCIENCE, 1996, 272 (5270) :1955-1958
[2]   Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: Identification by the combination of in situ polymerase chain reaction and immunohistochemistry [J].
Bagasra, O ;
Lavi, E ;
Bobroski, L ;
Khalili, K ;
Pestaner, JP ;
Tawadros, R ;
Pomerantz, RJ .
AIDS, 1996, 10 (06) :573-585
[3]   A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus type 1 strains [J].
Berson, JF ;
Long, D ;
Doranz, BJ ;
Rucker, J ;
Jirik, FR ;
Doms, RW .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6288-6295
[4]  
BRASS LF, 1994, J BIOL CHEM, V269, P2943
[5]   The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates [J].
Choe, H ;
Farzan, M ;
Sun, Y ;
Sullivan, N ;
Rollins, B ;
Ponath, PD ;
Wu, LJ ;
Mackay, CR ;
LaRosa, G ;
Newman, W ;
Gerard, N ;
Gerard, C ;
Sodroski, J .
CELL, 1996, 85 (07) :1135-1148
[6]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-2 INFECTION AND FUSION OF CD4-NEGATIVE HUMAN CELL-LINES - INDUCTION AND ENHANCEMENT BY SOLUBLE CD4 [J].
CLAPHAM, PR ;
MCKNIGHT, A ;
WEISS, RA .
JOURNAL OF VIROLOGY, 1992, 66 (06) :3531-3537
[7]   SPECIFIC CELL-SURFACE REQUIREMENTS FOR THE INFECTION OF CD4-POSITIVE CELLS BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AND TYPE-2 AND BY SIMIAN IMMUNODEFICIENCY VIRUS [J].
CLAPHAM, PR ;
BLANC, D ;
WEISS, RA .
VIROLOGY, 1991, 181 (02) :703-715
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VARIANTS WITH INCREASED REPLICATIVE CAPACITY DEVELOP DURING THE ASYMPTOMATIC STAGE BEFORE DISEASE PROGRESSION [J].
CONNOR, RI ;
HO, DD .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4400-4408
[9]   CD4 IS RETAINED IN THE ENDOPLASMIC-RETICULUM BY THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GLYCOPROTEIN PRECURSOR [J].
CRISE, B ;
BUONOCORE, L ;
ROSE, JK .
JOURNAL OF VIROLOGY, 1990, 64 (11) :5585-5593
[10]   Simian immunodeficiency virus infection of CD8(+) lymphocytes in vivo [J].
Dean, GA ;
Reubel, GH ;
Pedersen, NC .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5646-5650